O Gefvert

Summary

Affiliation: Central Hospital
Country: Sweden

Publications

  1. ncbi request reprint D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study
    O Gefvert
    Department of Psychiatric Research, Central Hospital, S 721 89, Vasteras, Sweden
    Eur Neuropsychopharmacol 11:105-10. 2001
  2. ncbi request reprint Different corticostriatal patterns of L-DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine
    Ola Gefvert
    Department of Psychiatry, Vasteras, Sweden
    Scand J Psychol 44:289-92. 2003
  3. ncbi request reprint Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta) in patients with schizophrenia
    Ola Gefvert
    Centre for Clinical Research, University of Uppsala, Central Hospital Västerås, Sweden
    Int J Neuropsychopharmacol 8:27-36. 2005
  4. ncbi request reprint Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic
    W Wolfgang Fleischhacker
    Department of Biological Psychiatry, Innsbruck University Clinics, Anichstrasse 35, 6020 Innsbruck, Austria
    J Clin Psychiatry 64:1250-7. 2003

Detail Information

Publications4

  1. ncbi request reprint D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study
    O Gefvert
    Department of Psychiatric Research, Central Hospital, S 721 89, Vasteras, Sweden
    Eur Neuropsychopharmacol 11:105-10. 2001
    ....
  2. ncbi request reprint Different corticostriatal patterns of L-DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine
    Ola Gefvert
    Department of Psychiatry, Vasteras, Sweden
    Scand J Psychol 44:289-92. 2003
    ..Treatment with clozapine or classical neuroleptics induces partial, albeit differential, normalization of the abnormal patterns seen in untreated schizophrenia...
  3. ncbi request reprint Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta) in patients with schizophrenia
    Ola Gefvert
    Centre for Clinical Research, University of Uppsala, Central Hospital Västerås, Sweden
    Int J Neuropsychopharmacol 8:27-36. 2005
    ..1 and 22.5-26.3 ng/ml respectively. The results indicate that brain D2 receptor occupancy at steady state after injections of long-acting risperidone was in the range found in patients effectively treated with 2-6 mg of oral risperidone...
  4. ncbi request reprint Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic
    W Wolfgang Fleischhacker
    Department of Biological Psychiatry, Innsbruck University Clinics, Anichstrasse 35, 6020 Innsbruck, Austria
    J Clin Psychiatry 64:1250-7. 2003
    ..The long-term safety and efficacy of long-acting injectable risperidone, the first long-acting second-generation antipsychotic, were evaluated in stable patients with schizophrenia...